Cao Xinling, Zhang Jingjing, Apaer Shadike, Yao Gang, Li Tao
Department of Liver Transplantation & Laparoscopic Surgery, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830054, People's Republic of China.
Department of Nephrology, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, Xinjiang 830054, People's Republic of China.
Int J Gen Med. 2021 Jan 13;14:89-102. doi: 10.2147/IJGM.S278538. eCollection 2021.
Recent researches have suggested that microRNA (miR)-19a-3p and miR-376c-3p might function as initiators in diverse cancers. Based on which, in this current study, we aimed to probe into the combined effects and mechanisms of miR-19a-3p and miR-376c-3p in hepatocellular carcinoma (HCC) cells.
Tumor tissues and adjacent normal tissues from 21 cases of HCC patients, HCC cell lines, and human normal liver cell lines were used in this study. RT-qPCR and Western blot were implemented to detect the expression of miR-19a-3p, miR-376c-3p, SOX6, and Wnt/β-catenin pathway-associated factors in HCC tissues and cells. The direct relationships between miR-19a-3p or miR-376c-3p and SOX6 were confirmed by luciferase activity assay. HCC cells were treated with miR-19a-3p inhibitor, miR-376c-3p inhibitor, or oe-SOX-6 to figure out their functions in HCC malignancy. The in vivo assays were conducted for the confirmation of in vitro results.
In both HCC tissues and cells, miR-19a-3p and miR-376c-3p were highly expressed, and SOX6 was poorly expressed. Depleted miR-19a-3p or miR-376c-3p was found to result in retarded HCC development. Bioinformatics analysis and luciferase activity assay revealed that SOX6 was the common target gene of miR-19a-3p and miR-376c-3p. Overexpressed SOX6 was demonstrated to block the Wnt/β-catenin pathway, thereby slowing down HCC progression. The in vivo assays showed that suppressed miR-19a-3p or miR-376c-3p and elevated SOX6 could reduce the tumor volume and weight of nude mice.
This study suggests that miR-19a-3p/miR-376c-3p activates the Wnt/β-catenin pathway via targeting SOX6, contributing to promoted biological functions of HCC cells.
近期研究表明,微小RNA(miR)-19a-3p和miR-376c-3p可能在多种癌症中发挥起始作用。基于此,在本研究中,我们旨在探究miR-19a-3p和miR-376c-3p在肝癌(HCC)细胞中的联合作用及机制。
本研究使用了21例HCC患者的肿瘤组织及癌旁正常组织、HCC细胞系和人正常肝细胞系。采用逆转录定量聚合酶链反应(RT-qPCR)和蛋白质免疫印迹法检测HCC组织和细胞中miR-19a-3p、miR-376c-3p、SOX6及Wnt/β-连环蛋白通路相关因子的表达。通过荧光素酶活性测定法确认miR-19a-3p或miR-376c-3p与SOX6之间的直接关系。用miR-19a-3p抑制剂、miR-376c-3p抑制剂或过表达SOX6(oe-SOX-6)处理HCC细胞,以明确它们在HCC恶性进展中的作用。进行体内实验以证实体外实验结果。
在HCC组织和细胞中,miR-19a-3p和miR-376c-3p均高表达,而SOX6低表达。发现降低miR-19a-3p或miR-376c-3p可导致HCC进展受阻。生物信息学分析和荧光素酶活性测定表明,SOX6是miR-19a-3p和miR-376c-3p的共同靶基因。过表达SOX6可阻断Wnt/β-连环蛋白通路,从而减缓HCC进展。体内实验表明,抑制miR-19a-3p或miR-376c-3p以及提高SOX6水平可减小裸鼠的肿瘤体积和重量。
本研究表明,miR-19a-3p/miR-376c-3p通过靶向SOX6激活Wnt/β-连环蛋白通路,促进HCC细胞的生物学功能。